Home » Stocks » OPNT

Opiant Pharmaceuticals, Inc. (OPNT)

Stock Price: $8.41 USD -0.02 (-0.19%)
Updated December 3, 2:51 PM EST - Market open

Stock Price Chart

Key Info

Market Cap 35.83M
Revenue (ttm) 27.37M
Net Income (ttm) -108,824
Shares Out 4.26M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE 26.74
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day December 3
Last Price $8.41
Previous Close $8.43
Change ($) -0.02
Change (%) -0.19%
Day's Open 8.42
Day's Range 8.29 - 8.48
Day's Volume 4,781
52-Week Range 6.87 - 14.89

More Stats

Market Cap 35.83M
Enterprise Value 5.13M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 4.26M
Float n/a
EPS (basic) -0.04
EPS (diluted) -0.03
FCF / Share 1.51
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 17.90%
Payout Ratio n/a
Shares Short 5,370
Short Ratio 0.37
Short % of Float n/a
Beta 0.78
PE Ratio n/a
Forward PE 26.74
P/FCF Ratio 5.59
PS Ratio 1.31
PB Ratio 1.01
Revenue 27.37M
Operating Income -493,133
Net Income -108,824
Free Cash Flow 6.41M
Net Cash 30.70M
Net Cash / Share 7.21
Gross Margin 86.66%
Operating Margin -1.80%
Profit Margin -0.40%
FCF Margin 23.43%
ROA -0.74%
ROE -0.32%
ROIC -4.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$40.00*
(375.40% upside)
Low
38.0
Current: $8.41
High
42.0
Target: 40.00
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue40.5213.9818.459.901.55-----
Revenue Growth189.8%-24.2%86.37%538.55%------
Gross Profit40.5213.9818.459.901.55-----
Operating Income10.91-21.197.09-7.74-6.90-11.30-8.81-12.34-9.44-2.02
Net Income11.59-21.206.58-7.81-7.04-11.48-9.18-12.42-9.44-2.02
Shares Outstanding4.022.992.011.911.811.751.431.040.670.87
Earnings Per Share2.17-7.102.94-4.09-3.88-6.57-6.00-12.00-14.00-2.00
Operating Cash Flow4.06-0.525.56-0.92-4.24-1.01-0.75-1.10-2.96-0.38
Capital Expenditures-0.30---0.01------
Free Cash Flow3.76-0.525.56-0.92-4.24-1.01-0.75-1.10-2.96-0.38
Cash & Equivalents30.9824.616.871.480.430.250.600.020.050.00
Total Debt0.77--0.17--0.030.22--
Net Cash / Debt30.2124.616.871.320.430.250.57-0.200.050.00
Assets40.2829.3910.811.880.490.300.640.040.080.02
Liabilities5.8612.536.476.598.873.381.630.660.420.66
Book Value34.4216.864.33-4.70-8.39-3.08-0.99-0.62-0.34-0.64
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Opiant Pharmaceuticals, Inc.
Employees 21

Stock Information

Ticker Symbol OPNT
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: OPNT

Description

Opiant Pharmaceuticals, a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes treatments for opioid overdose; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Santa Monica, California.